Impact of statewide program to promote appropriate antimicrobial drug use

Emerging Infectious Diseases

Volumn 11, Issue 6, 2005, Pages 912-920

  Belongia, Edward A ^a   Knobloch, Mary Jo ^a   Kieke Jr , Burney A ^a   Davis, Jeffrey P ^b   Janette, Carolyn ^b,d   Besser, Richard E ^c  

^a MARSHFIELD CLINIC   (United States)

^b Wisconsin Medical Society   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d MERITER HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; MACROLIDE; QUINOLONE DERIVATIVE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; HEALTH CARE POLICY; HEALTH PROMOTION; HUMAN; HUMAN EXPERIMENT; MASS COMMUNICATION; MEDICAL EDUCATION; MEDICAL PRACTICE; PEDIATRIC HOSPITAL; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; UNITED STATES;

ANTI-BACTERIAL AGENTS; COMMUNICATIONS MEDIA; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; EDUCATION, MEDICAL, CONTINUING; GOVERNMENT PROGRAMS; HEALTH EDUCATION; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PRESCRIPTIONS, DRUG; PROGRAM EVALUATION; WISCONSIN;

EID: 19344370166     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Whitney C, Farley M, Hadler J, Harrison L, Lexau C, Reingold A, et al. increasing prevalence of multidrug resistant Streptococcus pneumoniae in the United States. N Engl J Med. 2000;343:1917-24.
2. Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998;279:593-8.
3. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290:2976-84.
4. Arason V, Kristinsson K, Sigurdsson J, Stefansdottir G, Molstad S, Gudmundsson S. Do antimicrobials increase the carriage rate of penicillin-resistant pneumococci in children? Cross-sectional prevalence study. BMJ. 1996;313:387-91.
5. Albrich W, Monnet D, Harbarth S. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis. 2004;10:514-7.
6. Ho PL, Tse WS, Tsang KWT, Kwok TK, Ng TK, Cheng VCC, et al. Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study. Clin Infect Dis. 2001;32:701-7.
7. Nava JM, Bella F, Garau J, Lite J, Morera MA, Marti C, et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis 1994;19:884-90.
8. Samore M, Magill M, Alder S, Severina E, Morrison-de Boer L, Lyon J, et al. High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission. Pediatrics. 2001;108:856-65.
9. Tan TQ, Mason EO Jr, Kaplan SL. Penicillin-resistant systemic pneumococcal infections in children: a retrospective case-control study. Pediatrics. 1993;92:761-7.
10. McCaig L, Hughes J. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA. 1995;273:214-9.
11. Nyquist AC, Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA. 1998;279:875-7.
12. Barden L, Dowell S, Schwartz B, Lackey C. Current attitudes regarding use of antimicrobial agents: results from physicians' and parents' focus group discussions. Clin Pediatr. 1998;37:665-71.
13. Bauchner H, Pelton S, Klein J. Parents, physicians, and antibiotic use. Pediatrics. 1999;103:395-401.
14. Watson R, Dowell S, Jayaraman M, Keyserling H, Kolczak M, Schwartz B. Antimicrobial use for pediatric upper respiratory infections: reported practice, actual practice, and parent beliefs. Pediatrics. 1999;104:1251-7.
15. Wang E, Einarson T, Kellner J, Conly J. Antibiotic prescribing for Canadian preschool children: evidence of overprescribing for viral respiratory infections. Clin Infect Dis. 1999;29:155-60.
16. Schwartz RH, Freij BJ, Ziai M, Sheridan MJ. Antimicrobial prescribing for acute purulent rhinitis in children: a survey of pediatricians and family practitioners. Pediatr Infect Dis J. 1997;16:185-90.
17. Harrison PF, Lederberg J, editors. Antimicrobial resistance: issues and options. Institute of Medicine workshop report. Washington: National Academy Press; 1998.
18. Belongia E, Naimi T, Gale C, Besser R. Antibiotic use and upper respiratory infections: a survey of knowledge, attitudes, and experience in Wisconsin and Minnesota. Prev Med. 2002;34:346-52.
19. Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance: a systematic review of the effect of continuing medical education strategies. JAMA. 1995;274:700-5.
20. Gonzales R, Steiner J, Lum A, Barrett P. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA. 1999;281:1512-8.
21. Avorn J, Solomon DH. Cultural and economic factors that (mis)shape antibiotic use: the nonpharmacologic basis of therapeutics. Ann Intern Med. 2000;133:128-35.
22. McCaig L, Besser R, Hughes J. Trends in antimicrobial prescribing rates for children and adolescents. JAMA. 2002;287:3096-102.
23. Steinman M, Gonzales R, Linder J, Landefeld C. Changing use of antibiotics in community-based outpatient practice, 1991-1999. Ann Intern Med. 2003;138:525-33.
24. Finkelstein JA, Stille C, Nordin J, Davis R, Raebel MA, Roblin D, et al. Reduction in antibiotic use among US children, 1996-2000. Pediatrics. 2003;112:620-7.
25. Naimi TS, Smith KE, Besser J, Lynfield R. Antimicrobial resistance and judicious antimicrobial use in Minnesota and the United States. Minn Med. 2001;84:27-31.
26. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
27. Gonzales R, Sauaia A, Corbett KK, Maselli JH, Erbacher K, Leeman-Castillo BA, et al. Antibiotic treatment of acute respiratory tract infections in the elderly: effect of a multidimensional educational intervention. J Am Geriatr Soc. 2004;52:39-45.
28. Welschen I, Kuyvenhoven MM, Hoes AW, Verheij TJ. Effectiveness of a multiple intervention to reduce antibiotic prescribing for respiratory tract symptoms in primary care: randomised controlled trial. BMJ. 2004;329:431.
29. Doyne EO, Alfaro MP, Siegel RM, Atherton HD, Schoettker PJ, Bernier J, et al. A randomized controlled trial to change antibiotic prescribing patterns in a community. Arch Pediatr Adolesc Med. 2004;158:577-83.
30. Finkelstein JA, Davis RL, Dowell SF, Metlay JP, Soumerai SB, Rifas-Shiman SL, et al. Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics. 2001;108:1-7.
31. Macfarlane J, Holmes W, Gard P, Thornhill D, Macfarlane R, Hubbard R. Reducing antibiotic use for acute bronchitis in primary care: blinded, randomised controlled trial of patient information leaflet. BMJ. 2002;324:91-4.
32. Hennessy T, Petersen K, Bruden D, Parkinson A, Hurlburt D, Getty M, et al. Changes in antibiotic-prescribing practices and carriage of penicillin-resistant Streptococcus pneumoniae: s controlled interven-tion trial in Alaska. Clin Infect Dis. 2002;34:1543-50.
33. Mainous AG, Hueston WJ, Davis MP, Pearson WS. Trends in antimicrobial prescribing for bronchitis and upper respiratory infections among adults and children. Am J Public Health. 2003;93:1910-4.
34. Perz J, Craig A, Coffey C, Jorgensen D, Mitchel E, Hall S, et al. Changes in antibiotic prescribing for children after a community-wide campaign. JAMA. 2002;287:3103-9.
35. Dowell S. Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections. Pediatrics. 1998;101(Suppl): 163-84.
36. Gonzales R, Bartlett JG, Besser RE, Cooper RJ, Hickner JM, Hoffman JR, et al. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med. 2001;134:479-86.
37. Gonzales R, Bartlett JG, Besser RE, Hickner JM, Hoffman JR, Sande MA. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Ann Intern Med. 2001;134:490-4.
38. Kiang KM, Kieke BA, Como-Sabetti K, Lynfield R, Besser RE, Belongia EA. Clinician knowledge and beliefs after statewide program to promote appropriate antimicrobial drug education campaign. Emerg Infect Dis. 2005;11:904-11.
39. Finch RG, Metlay JP, Davey PG, Baker LJ. Educational interventions to improve antibiotic use in the community: report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002. Lancet Infect Dis. 2004;4:44-53.